Fluid Management in Patients with Chronic Heart Failure
- PMID: 28785439
- PMCID: PMC5490880
- DOI: 10.15420/cfr.2015.1.2.90
Fluid Management in Patients with Chronic Heart Failure
Abstract
Congestion, or fluid overload, is a classic clinical feature of patients presenting with heart failure patients, and its presence is associated with adverse outcome. However, congestion is not always clinically evident, and more objective measures of congestion than simple clinical examination may be helpful. Although diuretics are the mainstay of treatment for congestion, no randomised trials have shown the effects of diuretics on mortality in chronic heart failure patients. Furthermore, appropriate titration of diuretics in this population is unclear. Research is required to determine whether a robust method of detecting - and then treating - subclinical congestion improves outcomes.
Keywords: Diuretics; chronic heart failure; congestion; review; treatment.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
How to use diuretics in heart failure.Curr Treat Options Cardiovasc Med. 2009 Dec;11(6):426-32. doi: 10.1007/s11936-009-0045-1. Curr Treat Options Cardiovasc Med. 2009. PMID: 19930980
-
Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure.Cardiovasc Drugs Ther. 2016 Dec;30(6):599-609. doi: 10.1007/s10557-016-6697-7. Cardiovasc Drugs Ther. 2016. PMID: 27819111 Clinical Trial.
-
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure.Card Fail Rev. 2021 Jun 12;7:e19. doi: 10.15420/cfr.2021.22. eCollection 2021 Mar. Card Fail Rev. 2021. PMID: 34950509 Free PMC article. Review.
-
Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.Heart Fail Rev. 2012 Mar;17(2):313-24. doi: 10.1007/s10741-011-9248-0. Heart Fail Rev. 2012. PMID: 21559880 Review.
-
Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.Future Cardiol. 2023 Jun;19(8):385-396. doi: 10.2217/fca-2023-0071. Epub 2023 Aug 23. Future Cardiol. 2023. PMID: 37609913
Cited by
-
Psychosocial Risk and Health Behaviors as Predictors of Clinical Events in Patients Wait-Listed for a New Heart: Results from 7 Years of Follow-Up.Life (Basel). 2021 Dec 20;11(12):1438. doi: 10.3390/life11121438. Life (Basel). 2021. PMID: 34947969 Free PMC article.
-
Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions.J Clin Med. 2024 Oct 30;13(21):6502. doi: 10.3390/jcm13216502. J Clin Med. 2024. PMID: 39518641 Free PMC article. Review.
-
2017 Writing Contest Undergraduate Winner: Pathways to Preventable Hospitalizations for Filipino Patients with Diabetes and Heart Disease in Hawai'i.Hawaii J Med Public Health. 2018 Jul;77(7):155-160. Hawaii J Med Public Health. 2018. PMID: 30009093 Free PMC article.
-
Early Diuretics for De-resuscitation in Septic Patients With Left Ventricular Dysfunction.Clin Med Insights Cardiol. 2022 May 13;16:11795468221095875. doi: 10.1177/11795468221095875. eCollection 2022. Clin Med Insights Cardiol. 2022. PMID: 35592767 Free PMC article.
-
Critical Insights Into the Management of Postpartum Left Main Spontaneous Coronary Artery Dissection: Current Strategies and Future Directions.Cureus. 2023 Sep 3;15(9):e44622. doi: 10.7759/cureus.44622. eCollection 2023 Sep. Cureus. 2023. PMID: 37799221 Free PMC article. Review.
References
-
- Cleland JG, McDonagh T, Rigby AS, et al; National Heart Failure Audit Team for England and Wales. The national heart failure audit for England and Wales 2008–2009. Heart. 2011;97:876–886. - PubMed
-
- Carson PE, Anand IS, Win S, et al. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015;3:429–441. - PubMed
-
- Clark AL, Cleland JG. Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol. 2013;10:156–170. - PubMed
-
- Shoaib A, Waleed M, Khan S, et al. Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail. 2014;16:1283–1291. - PubMed
-
- Ambrosy AP, Pang PS, Khan S, et al; EVEREST Trial Investigators. Clinical course and predictive value of congestion during hospitalisation in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34:835–843. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources